-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Initiates Coverage On Tyra Biosciences with Buy Rating, Announces Price Target of $50

Benzinga·04/06/2026 12:49:51
Listen to the news
Canaccord Genuity analyst John Newman initiates coverage on Tyra Biosciences (NASDAQ:TYRA) with a Buy rating and announces Price Target of $50.